Inactive Instrument
Raptor Pharmaceutical Corp Stock
Stocks
US75382F1066
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 61 | 25/10/2016 |
| Corporate Officer/Principal | 64 | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
BRD | Director/Board Member | 61 | 25/10/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | -7.19% | +51.66% | +69.99% | 65.83B | |
| +1.61% | +9.82% | +12.48% | +86.84% | 51.87B | |
| +5.32% | +6.90% | +5.23% | +69.47% | 51.2B | |
| +0.99% | +2.14% | +25.56% | +44.42% | 43.76B | |
| +1.57% | +8.25% | +18.61% | +128.74% | 42.09B | |
| +4.40% | -2.31% | +240.84% | +558.17% | 39.04B | |
| +2.16% | +9.87% | +18.92% | +59.70% | 34B | |
| +3.84% | -2.34% | +39.18% | +8.57% | 25.2B | |
| +1.57% | +4.29% | +29.68% | +24.81% | 22.8B | |
| Average | +2.50% | +0.27% | +49.13% | +116.75% | 41.76B | |
| Weighted average by Cap. | +2.46% | +0.20% | +47.71% | +118.77% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
